Artificial intelligence-driven new drug discovery targeting serine/threonine kinase 33 for cancer treatment.
Journal Information
Full Title: Cancer Cell Int
Abbreviation: Cancer Cell Int
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethical approval and consent to participateThe animal studies were performed with the approval of the Animal Care and Use Committee of the Korea Institute of Science and Technology and Korea Animal Protection Law. Consent for publicationAll listed authors consent to the submission, and all data are used with the consent of the person generating the data. Competing interestsDr. Eun Ko is a current employee of Standigm Inc. Competing interests Dr. Eun Ko is a current employee of Standigm Inc."
"Funding This work was supported and funded by Standigm Inc. This work was also supported in part by National Research Foundation (NRF) funded by Korean government (MIST) (No. RS-2023-00208795 and No. RS-2023-00260529 to S.J.O)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025